EyePoint, Inc (EYPT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $34.82M
Last updated: Nov 17, 2026 at 11:05 AM ET
EyePoint, Inc (EYPT) Competitors
The companies most similar to EyePoint are Hyperion DeFi (HYPD), OS Therapies (OSTX) and OKYO Pharma (OKYO). By market cap, EyePoint ranks 8th of the 13 companies on this page; OUTLOOK THERAPEUTICS INC (OTLK) is the largest at $100.54M.
Peer Comparison
EYPT's revenue growth of -21.7% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| EyePoint (EYPT) | $34.82M | N/A | 10.6x | 0.0% | N/A | -21.7% | 0.00% |
| Hyperion DeFi, Inc. (HYPD) | $39.84M | N/A | 20.3x | 474.9% | 22.2% | 1560.0% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| OKYO Pharma Limited (OKYO) | $70.85M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Edesa Biotech Inc (EDSA) | $26.21M | N/A | N/A | 0.0% | N/A | -99.9% | 0.00% |
| Pelthos Therapeutics Inc. (PTHS) | $29.24M | N/A | 0.5x | -199.5% | -95.4% | 0.0% | 0.00% |
| eXoZymes, Inc. (EXOZ) | $35.64M | N/A | N/A | 0.0% | -455.6% | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| OUTLOOK THERAPEUTICS INC (OTLK) | $100.54M | N/A | N/A | 0.0% | -776.9% | -99.4% | 0.00% |
| Connect Biopharma Holdings Ltd (CNTB) | $42.65M | N/A | 13.6x | 0.0% | N/A | 5667.0% | 0.00% |
| Quince Therapeutics, Inc. (QNCX) | $32.27M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Oncolytics Biotech Inc (ONCY) | $48.51M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Immutep Ltd ADR (IMMP) | $25.64M | N/A | 2.2x | 0.0% | N/A | 633.0% | 0.00% |
| Peer median | $35.25M | N/A | 2.2x | 0.0% | -275.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to EyePoint, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Hyperion DeFi, Inc. (HYPD) | Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. | HYPD competitors |
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| OKYO Pharma Limited (OKYO) | OKYO Pharma Limited, a preclinical biopharmaceutical company, is engaged in developing therapies for patients suffering from inflammatory eye diseases and eye... | |
| Edesa Biotech Inc (EDSA) | Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development... | EDSA competitors |
| Pelthos Therapeutics Inc. (PTHS) | Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. | PTHS competitors |
| eXoZymes, Inc. (EXOZ) | eXoZymes, Inc. is a synthetic biochemical company in the United States. The company is headquartered in Monrovia, California. | EXOZ competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| OUTLOOK THERAPEUTICS INC (OTLK) | Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic... | OTLK competitors |
| Connect Biopharma Holdings Ltd (CNTB) | Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators... | CNTB competitors |
| Quince Therapeutics, Inc. (QNCX) | Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases. | |
| Oncolytics Biotech Inc (ONCY) | Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. | ONCY competitors |
| Immutep Ltd ADR (IMMP) | Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates. |
Frequently Asked Questions About EYPT
Who are EyePoint's main competitors?
The companies most similar to EyePoint include Hyperion DeFi (HYPD), OS Therapies (OSTX), OKYO Pharma (OKYO), Edesa Biotech (EDSA) and Pelthos Therapeutics (PTHS), listed from the closest match.
Who is EyePoint's biggest competitor?
OUTLOOK THERAPEUTICS INC (OTLK) is the largest of the similar companies at $100.54M; Hyperion DeFi (HYPD) is the closest match by business profile, size, sector and industry.
How does EYPT stock compare with its competitors?
EYPT's P/S is 10.6x against a peer median of 2.2x; its net margin is 0.0% against a peer median of 0.0%.
Which of EyePoint's competitors pays a higher dividend?
EyePoint pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is EyePoint bigger than its competitors?
No. EyePoint is 8th by market cap among the 13 companies on this page; the largest is OUTLOOK THERAPEUTICS INC (OTLK) at $100.54M.
EYPT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors